---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-069619"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:43:22.524720+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Apogee Therapeutics shareholders elect three Class I directors, ratify auditor, approve option grant

## Summary
- Elected Andrew Gottesdiener, Peter Harwin, and Michael Henderson as Class I directors with >33.8M votes for each.
- Ratified Ernst & Young as independent auditor for FY 2024 with 41.56M votes for, 2,163 against.
- Approved grant of options for 100,000 shares to a director with 40.43M votes for, 330,671 against.
- All proposals passed with broker non-votes of 805,441 on director election and option grant.

## SEC filing metadata
- accession: 0001104659-24-069619
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000110465924069619/0001104659-24-069619-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000110465924069619/tm2416675d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-069619
- JSON: https://secwatch.observer/filing/0001104659-24-069619.json
- Plain text: https://secwatch.observer/filing/0001104659-24-069619.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.